Microscopic cells
Science & Technology
May 31, 2022

The future of cell therapy: Novel study tests treatment for radiation-induced dry mouth

For certain side effects of complex and lifesaving medical procedures, care teams can be left with limited and risky treatment options, but a program at UW Health is changing that using patients’ own cells as “living therapeutics.”

Dr. Douglas McNeel
Science & Technology
May 11, 2022

Future of health: Cancer vaccines

When people consider vaccines, many think about the pandemic and about preventing illness. However, certain UW researchers have a very different focus when they work with vaccines.

sharks
Science & Technology
January 14, 2022

UW–Madison expert launches novel cancer research using sharks

There are some new residents on the University of Wisconsin–Madison campus, but they aren’t students, they’re sharks.

Cancer Center Cessation
Health & Wellness
December 10, 2021

Cancer Center Cessation Initiative launches new effort to help cancer patients quit smoking

It’s well documented that smoking can lead to cancer. But in recent years, evidence has been mounting that continuing to smoke during cancer treatment can be just as harmful, or even worse.

A large machine for taking patient scans
Health & Wellness
November 29, 2021

Lung cancer screening guidelines may perpetuate disparities in health care

Recent changes to national guidelines made more former and current smokers eligible for lung cancer screening, but a new study by a University of Wisconsin School of Medicine and Public Health radiologist shows they did little to close the gap between people of color and white people when it comes to who is eligible to get the scan.

A patient getting an upper body scan
Health & Wellness
November 29, 2021

Access to Medicare increases lung cancer screening rates

If lung cancer is caught early enough, it’s treatable with a high chance of long survival. But many people at high risk because of their smoking history aren’t screened until they turn 65 and are eligible for Medicare coverage.

Health & Wellness
June 4, 2021

UW researchers focus on boosting colorectal cancer screening rates in rural areas

Researchers at UW Carbone Cancer Center are working to understand why some primary care clinics in rural locations have successfully attained high rates of colorectal cancer screenings, insight they hope will help raise the rates of colorectal cancer screenings across all rural clinics.

Science & Technology
May 20, 2021

Patient with rare cancer uses telehealth to access clinical trial

Today is National Clinical Trials Day, and UW Health wants to celebrate the researchers, nurses, physicians and experts in the lab who make clinical trials available and impactful for our patients and community. UW Health officials also say virtual consultations have been vital to expanding access to clinical trials for Wisconsin residents, especially during the pandemic.

Nataliya Uboha
Honors & Awards
March 29, 2021

Nataliya Uboha named faculty leader of Cancer Therapy Discovery and Development (CTD2) at UW Carbone Cancer Center

Nataliya Uboha, MD, PhD, has been selected to lead the Cancer Therapy Discovery and Development (CTD2) program at the University of Wisconsin Carbone Cancer Center.

Science & Technology
February 18, 2021

Study finds analyzing DNA in urine could help detect cancer

A study published this week in Science Translational Medicine describes how urinalysis could potentially be used to detect some forms of cancer.

Immune cells and tumor cells at 2 hours and 24 hours
Science & Technology
January 7, 2021

Jamey Weichert, Zachary Morris leading a team to develop new way to help immune system fight back against cancer

Scientists at the University of Wisconsin School of Medicine and Public Health are breaking new ground to make cancer cells more susceptible to attack by the body’s own immune system.

American Family Children's Hospital building exterior
Science & Technology
November 19, 2020

First-in-humans clinical trial to treat children with relapsed neuroblastoma opens at American Family Children’s Hospital

A first-in-humans clinical trial for children with relapsed or refractory neuroblastoma has opened at American Family Children’s Hospital (AFCH) and is being conducted by researchers at University of Wisconsin School of Medicine and Public Health. Neuroblastoma is one of the most common solid tumors in children. Patients who are classified as “high-risk” (about 40 percent of those diagnosed) have less than a 50 percent survival rate.